ArticlePeerJ2025
Optimizing carbon nanoparticle staining for sentinel lymph nodes in rabbit lower limb models: concentration and time dependence.
Article in PeerJ, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Nanoplatforms for Sentinel and Tumor-Draining Lymph Node Mapping: From Visualization to Pathway-Informed Staging.Advanced healthcare materials · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Objectives: Carbon nanoparticles (CNPs) have been used as a lymphatic imaging agent that can selectively enter lymphatic vessels. This experiment used CNPs for lower limb lymph node staining in rabbits, aiming to explore the suitable concentration and time of CNPs for sentinel lymph node (SLN) sufficient staining, and the biosafety of CNPs retention was preliminarily explored. Methods: Staining effect of SLN using different concentrations of CNP injection on the rabbit lower limb lymphatic model. To explore the temporal correlation of CNPs staining. We investigated the effects of long-term retention of CNPs in lymph nodes on lymph node tissue structure and mRNA expression of inflammatory factors (IL-6/TNF-α), apoptosis factors (Bcl-2/Bax), and fibrosis factors (Collagen-I/α-SMA). Results: The lowest concentration to achieve adequate lymph node staining is 0.0781 mg/0.8 mL, while the best staining results were observed at least 12 hours post-injection. Long-term CNPs retention has no significant negative impact on the structure and function of lymph nodes. Conclusions: CNPs are an effective and safe lymphatic tracer. It is a concentration-dependent and time-dependent lymphatic staining agent. 0.0781 mg/0.8 mL and 12 hours are suitable for the rabbit lower limb lymphatic staining model, which provides valuable data for further research on the application of CNPs in rabbit animal models. In addition, the results provide evidence for future clinical development of concentration and time standards for CNPs' use.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.